OpsoVac

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOpsoVac
Drug Alias Nameadjuvant vaccine (Opsona/CSL)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrinity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl LtdOpsona Therapeutics LtdTrinity College Dublin
Active IndicationsN/A
Inactive IndicationsNeoplasmsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A